Free Trial

Fate Therapeutics (FATE) SEC Filings & 10K Form

Fate Therapeutics logo
$1.11 +0.06 (+5.71%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$1.11 0.00 (0.00%)
As of 04/17/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Fate Therapeutics SEC Filings

DateFilerForm TypeView
04/17/2025
3:05 PM
Fate Therapeutics (Filer)
Form DEF 14A
04/17/2025
3:07 PM
Fate Therapeutics (Filer)
Form DEFA14A
04/17/2025
3:09 PM
Fate Therapeutics (Filer)
Form ARS
04/07/2025
3:01 PM
Fate Therapeutics (Filer)
Form PRE 14A
03/06/2025
12:52 PM
Fate Therapeutics (Subject)
Wolchko J Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
5:31 PM
Bressi Jerome Charles (Reporting)
Fate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
5:32 PM
Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
5:36 PM
Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:05 PM
Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:06 PM
Bressi Jerome Charles (Reporting)
Fate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
2:12 PM
Fate Therapeutics (Subject)
TAHL CINDY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
2:12 PM
Bressi Jerome Charles (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
2:20 PM
Fate Therapeutics (Subject)
Valamehr Bahram (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2024
8:00 PM
Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SCHEDULE 13D/A
12/26/2024
8:00 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
8:00 PM
Fate Therapeutics (Subject)
Redmile Group, LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
8:00 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
1:33 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:50 PM
Fate Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
10/25/2024
8:37 PM
Boxer Capital Management, LLC (Filed by)
Fate Therapeutics (Subject)
Form SC 13G/A
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Fate Therapeutics (Subject)
Form SC 13G/A
08/30/2024
3:21 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
3:01 PM
Fate Therapeutics (Issuer)
Xu Yuan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
9:34 AM
Fate Therapeutics (Subject)
Xu Yuan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2024
4:59 PM
Fate Therapeutics (Issuer)
Mozaffarian Neelufar (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/31/2024
5:00 PM
Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:01 PM
Fate Therapeutics (Issuer)
Mozaffarian Neelufar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:05 PM
Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:03 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
5:19 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
5:20 PM
Fate Therapeutics (Issuer)
Lee Michael Stewart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:35 PM
Fate Therapeutics (Issuer)
RASTETTER WILLIAM H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:30 PM
Fate Therapeutics (Issuer)
Jooss Karin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
4:05 PM
Fate Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/10/2024
3:31 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
4:26 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
4:24 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
8:01 AM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
11:15 PM
Fate Therapeutics (Filer)
Form EFFECT
04/26/2024
3:16 PM
Fate Therapeutics (Filer)
Form ARS
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FATE) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners